HSBC Holdings’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,434
Closed -$24K 3182
2025
Q1
$24K Buy
33,434
+138
+0.4% +$95 ﹤0.01% 2959
2024
Q4
$26.8K Buy
33,296
+2,663
+9% +$2.44K ﹤0.01% 3040
2024
Q3
$29.8K Buy
+30,633
New +$42K ﹤0.01% 2921
2022
Q3
Sell
-12,746
Closed -$30K 3164
2022
Q2
$30K Sell
12,746
-3,888
-23% -$9.3K ﹤0.01% 3175
2022
Q1
$55K Buy
16,634
+146
+0.9% +$513 ﹤0.01% 3192
2021
Q4
$77K Buy
+16,488
New +$125K ﹤0.01% 3171
2021
Q3
Sell
-11,241
Closed -$92K 3111
2021
Q2
$92K Buy
+11,241
New +$94.9K ﹤0.01% 2855

Other funds holding OCGN

HSBC Holdings's OCGN Position: Q2 2025 in Review

HSBC Holdings sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 33,434 shares — an estimated $24K sold.

HSBC Holdings first reported a position in OCGN in Q2 2021 and held it in 7 quarters. The position peaked at $92K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • HSBC Holdings reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 33,434 Ocugen shares in Q2 2025, an estimated $24K.
  • HSBC Holdings first reported a position in Ocugen in Q2 2021 and held it in 7 quarters.
  • HSBC Holdings's Ocugen position peaked at $92K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.